Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells-Reference-Cited by-同舟云学术

Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells

Published:2011-08 Issue:9-10 Volume:89 Page:304-312
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Adamczyk Kamila A.,Klein-Scory Susanne,Tehrani Mahnaz Moradian,Warnken Uwe,Schmiegel Wolff,Schnölzer Martina,Schwarte-Waldhoff Irmgard

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference49 articles.

1. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation;Basu;Mol Cell Biol,1989

2. Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique;Bloomston;Dig Surg,2006

3. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma;Bruns;Cancer Res,2000

4. Shedding microvesicles: artefacts no more;Cocucci;Trends Cell Biol,2009

5. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High expression of CD9 and Epidermal Growth Factor Receptor promotes the development of tongue cancer;Medical Oncology;2024-03-12

2. Early cancer detection based on exosome biosensors in biological samples;Sensors and Actuators B: Chemical;2024-02

3. Mass Spectrometry-based Proteomics Technology in Pancreatic Cancer Research;Journal of Pancreatology;2023-11-14

4. Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance;Cancers;2023-09-25

5. Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody–Gaussia Luciferase Fusion Protein;Pharmaceutics;2023-07-19